Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

por Simpson, G R, Horvath, A, Annels, N E, Pencavel, T, Metcalf, S, Seth, R, Peschard, P, Price, T, Coffin, R S, Mostafid, H, Melcher, A A, Harrington, K J, Pandha, H S
Publicado 2012

Risk profiles of prostate cancers identified from UK primary care using national referral guidelines

por Serag, H, Banerjee, S, Saeb-Parsy, K, Irving, S, Wright, K, Stearn, S, Doble, A, Gnanapragasam, V J
Publicado 2012

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML

por Lin, W-H, Jiaang, W-T, Chen, C-W, Yen, K-J, Hsieh, S-Y, Yen, S-C, Chen, C-P, Chang, K-Y, Chang, C-Y, Chang, T-Y, Huang, Y-L, Yeh, T-K, Chao, Y-S, Chen, C-T, Hsu, J T-A
Publicado 2012

ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours

por Karger, S, Krause, K, Gutknecht, M, Schierle, K, Graf, D, Steinert, F, Dralle, H, Führer, D
Publicado 2012

Estimating the asbestos-related lung cancer burden from mesothelioma mortality

por McCormack, V, Peto, J, Byrnes, G, Straif, K, Boffetta, P
Publicado 2012

The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovari...

por Coley, H M, Safuwan, N A M, Chivers, P, Papacharalbous, E, Giannopoulos, T, Butler-Manuel, S, Madhuri, K, Lovell, D P, Crook, T
Publicado 2012

Potential role of a navigator gene NAV3 in colorectal cancer

por Carlsson, E, Ranki, A, Sipilä, L, Karenko, L, Abdel-Rahman, W M, Ovaska, K, Siggberg, L, Aapola, U, Ässämäki, R, Häyry, V, Niiranen, K, Helle, M, Knuutila, S, Hautaniemi, S, Peltomäki, P, Krohn, K
Publicado 2012

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors

por Xu, Y, Brenn, T, Brown, E R S, Doherty, V, Melton, D W
Publicado 2012

A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes

por Dutta, B, Pusztai, L, Qi, Y, André, F, Lazar, V, Bianchini, G, Ueno, N, Agarwal, R, Wang, B, Shiang, C Y, Hortobagyi, G N, Mills, G B, Symmans, W F, Balázsi, G
Publicado 2012

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

por Harder, J, Ihorst, G, Heinemann, V, Hofheinz, R, Moehler, M, Buechler, P, Kloeppel, G, Röcken, C, Bitzer, M, Boeck, S, Endlicher, E, Reinacher-Schick, A, Schmoor, C, Geissler, M
Publicado 2012

Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway

por Maseki, S, Ijichi, K, Tanaka, H, Fujii, M, Hasegawa, Y, Ogawa, T, Murakami, S, Kondo, E, Nakanishi, H
Publicado 2012

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

por Robertson, L, Hanson, H, Seal, S, Warren-Perry, M, Hughes, D, Howell, I, Turnbull, C, Houlston, R, Shanley, S, Butler, S, Evans, D G, Ross, G, Eccles, D, Tutt, A, Rahman, N
Publicado 2012

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

por Cuzick, J, Berney, D M, Fisher, G, Mesher, D, Møller, H, Reid, J E, Perry, M, Park, J, Younus, A, Gutin, A, Foster, C S, Scardino, P, Lanchbury, J S, Stone, S
Publicado 2012

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

por Rakovitch, E, Nofech-Mozes, S, Hanna, W, Narod, S, Thiruchelvam, D, Saskin, R, Spayne, J, Taylor, C, Paszat, L
Publicado 2012

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation

por Fallowfield, L J, Kilburn, L S, Langridge, C, Snowdon, C F, Bliss, J M, Coombes, R C
Publicado 2012

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

por Yoon, D H, Ryu, M-H, Park, Y S, Lee, H J, Lee, C, Ryoo, B-Y, Lee, J-L, Chang, H-M, Kim, T W, Kang, Y-K
Publicado 2012

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

por Tikidzhieva, A, Benner, A, Michel, S, Formentini, A, Link, K-H, Dippold, W, von Knebel Doeberitz, M, Kornmann, M, Kloor, M
Publicado 2012

Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study

por Thomas, S, Pütter, C, Weber, S, Bornfeld, N, Lohmann, D R, Zeschnigk, M
Publicado 2012

Hedgehog pathway activation in human transitional cell carcinoma of the bladder

por Pignot, G, Vieillefond, A, Vacher, S, Zerbib, M, Debre, B, Lidereau, R, Amsellem-Ouazana, D, Bieche, I
Publicado 2012

The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting

por Kailayangiri, S, Altvater, B, Meltzer, J, Pscherer, S, Luecke, A, Dierkes, C, Titze, U, Leuchte, K, Landmeier, S, Hotfilder, M, Dirksen, U, Hardes, J, Gosheger, G, Juergens, H, Rossig, C
Publicado 2012